2019
DOI: 10.1016/j.burnso.2018.10.002
|View full text |Cite
|
Sign up to set email alerts
|

Biodegradable Temporising Matrix (BTM) for the reconstruction of defects following serial debridement for necrotising fasciitis: A case series

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
37
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 39 publications
(37 citation statements)
references
References 14 publications
0
37
0
Order By: Relevance
“…Moreover, the authors demonstrated that the BTM continued to integrate into the wound bed following drainage of infected collections through perforations in the seal. This, in turn, resulted in improved healing of those deep and extensive wounds [ 105 , 106 ]. In addition, the BTM has been also used for the reconstruction of soft tissue defects, such as on the anterior neck, lateral chest and flank, and knee from mid-thigh to distal leg [ 106 ].…”
Section: Applications Of Hydrogels For Wound Healingmentioning
confidence: 99%
“…Moreover, the authors demonstrated that the BTM continued to integrate into the wound bed following drainage of infected collections through perforations in the seal. This, in turn, resulted in improved healing of those deep and extensive wounds [ 105 , 106 ]. In addition, the BTM has been also used for the reconstruction of soft tissue defects, such as on the anterior neck, lateral chest and flank, and knee from mid-thigh to distal leg [ 106 ].…”
Section: Applications Of Hydrogels For Wound Healingmentioning
confidence: 99%
“…This case is published in isolation to illustrate a particular finding (tendon gliding under the material despite lack of paratenon), and readers should reference our previous work for other examples of outcome. 13,10 BTM is regulated in the United States under an FDA 510(k) (a regulatory pathway granted by the US Food and Drug Administration prior to a company commercialising its product, where evidence that the medical device intended to be marketed is safe and effective) for use in wounds (excluding deep burns) and can be used now by US surgeons for similar indications. It is fully regulated for use in any wound in Australia and is also available in South Africa, India, Saudi Arabia, and Israel.…”
Section: Discussionmentioning
confidence: 99%
“…1 The observed ability of BTM to resist infection and ability to integrate into large wound beds 2 prompted its use in the reconstruction of postdebridement necrotising fasciitis defects. 3…”
mentioning
confidence: 99%
“…Growing environmental pollution has forced the development of biodegradable polymers and, at the start of this millennium, Thilak Gunitillake at the Commonwealth Scientific, Industrial and Research Organisation (CSIRO) in Melbourne, Australia developed a family of biodegradable polyurethanes, now called NovoSorb. 1 A completely synthetic, biodegradable polyurethane dermal matrix was designed and developed in Adelaide and is progressively becoming more available: the NovoSorb TM Biodegradable Temporising Matrix (BTM), 1,[11][12][13][14][15][16][17][18][19][20][21][22][23] produced by PolyNovo Biomaterials Pty Ltd, Port Melbourne, Victoria, Australia.…”
mentioning
confidence: 99%
“…Thus, infection is uncommon and, if it does occur, is localised and manageable without loss of the matrix. 16,22,23 Increasing burns use also demonstrated that loss of skin graft over the integrated BTM is extremely rare and that the appearance of autograft mesh pattern (even with widely meshed graft) is considerably better than autograft alone. 22 This finding has also been observed with collagen-based matrices and has its basis in the principles of wound healing.…”
mentioning
confidence: 99%